Changing Diabetes in Children program receives four-year extension

Novo Nordisk's Changing Diabetes in Children program has received a four-year extension to provide access to diabetes care and free insulin to children in developing countries who have Type 1 diabetes.
“The Changing Diabetes in Children program has been iconic,” Diabetic Association of Bangladesh President Azad Khan said. “It has changed the lives of children with Type 1 diabetes in Bangladesh. Their survival depends on the supply of insulin as well as education on how to cope with diabetes, and the program provides all of this.”
The program’s expansion will include the addition of five countries: Cambodia, Ivory Coast, Myanmar, Senegal and Sudan. The program estimates that by 2020, approximately 20,000 children will have benefited from the program throughout its 11 years of existence.
“The provision of free medicine alone doesn’t solve complex healthcare challenges,” Novo Nordisk President and CEO Lars Rebien Sorensen said. “From the outset of this program, we have therefore worked closely with local partners to deliver sustainable solutions alongside insulin to improve the lives of children with Type 1 diabetes both now and in the future.”